In the latest trading session, Snowflake Inc. (SNOW) closed at $259.30, marking a +1.18% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.82%.Coming into today, shares of the company had gained 2.8% in the past month. In that same time, the Computer and Technology sector gained 1.27%, while the S&P 500 gained 3.89%.Wall Street will be looking for positivity from SNOW as it approaches its next earnings report date.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.57 per share and revenue of $1.11 billion. These totals would mark changes of +68.68% and +87.67%, respectively, from last year.Investors should also note any recent changes to analyst estimates for SNOW. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. SNOW is holding a Zacks Rank of #3 (Hold) right now.The Internet - Software industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 204, putting it in the bottom 20% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.To follow SNOW in the coming trading sessions, be sure to utilize Zacks.com. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Snowflake Inc. (SNOW): Free Stock Analysis Report To read this article on Zacks.com click here.